85824-1Carbapenem resistance blaIMP gene [Presence] by NAA with probe detectionDiscouraged
- Recommend using the term with System Isolate/Specimen and Method Molgen that aligns with the new LOINC model for molecular resistance testing that was approved by Laboratory LOINC Committee in June 2018
|Map-To||Long Common Name||Mapping Guidance|
|85498-4||Carbapenem resistance blaIMP gene [Presence] by Molecular method|
This test reports the presence of the IMP bacterial carbapenemase resistance type gene in gram negative bacterial isolates. This term was created for, but is not limited in use to, the submitter's modified protocol for the Check-Points Check-MDR CT103XL assay.
Source: Regenstrief LOINC
LP248294-3 Bacterial carbapenem resistance blaIMP gene
Plasmid-mediated IMP-type carbapenemases are currently known to have 17 varieties. Studies have revealed its establishment in Japan in the 1990s in enteric Gram-negative organisms, Pseudomonas species and Acinetobacter species. IMP genes usually co-exist with other resistance genes resulting in multi-drug resistance.
Studies have shown that a high percentage of patients with immunodeficiency and drug resistant nosocomial infections are infected with a VIM or IMP producing organism, particularly when the organism identified is pseudomonas aeruginosa. The two genes are often present together although they can also be present individually. Identifying the presence of these genes is important in monitoring drug resistance and determining the best antibiotic therapy methods.
[PMID: 27563634] [PMID: 28085553] Source: Regenstrief LOINC
LP265773-4 Bacterial ABXBACT probe.amp.tar
PCR-based Methods for bacterial susceptibility are similar to genotyping for viral susceptibility, in that resistance or susceptibility is inferred based on the presence or absence of specific genetic information that is known to encode resistance to a specific antibiotic or group of antibiotics. For bacteria, resistance is often conferred by genes that are carried on plasmids, which can be transferred from one species to another. These genes encode proteins that specifically inhibit certain antibiotics, such as carbapenems or aminoglycosides. Source: Regenstrief LOINC
- Bacterial carbapenem resistance blaIMP gene
- Short Name
- blaIMP Islt Ql NAA+probe
- Display Name
- Carbapenem resistance blaIMP gene NAA+probe Ql (Isol)
- First Released
- Version 2.61
- Last Updated
- Version 2.67
- Order vs. Observation
Example Answer List LL360-9
Source: Regenstrief Institute
|Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value)||LA6576-8|
|Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value)||LA6577-6|
Language Variants Get Info
- zh-CNChinese (CHINA)
- 细菌碳青霉烯类耐药 blaIMP 基因:
存在情况或阈值: 时间点: 分离株: 序数型: 探针法.基因扩增.靶向
- nl-NLDutch (NETHERLANDS)
- bacteriële carbapenemresistentie blaIMP-gen:
aanwezigheid: moment: isolaat: ordinaal: moleculaire techniek (PCR)
- fr-FRFrench (FRANCE)
- Résistance bactérienne aux carbapénèmases blaIMP gène:
Présence/Seuil: Ponctuel: Isolat: Qualitatif: PCR amplification de cible
- it-ITItalian (ITALY)
- Resistenza batterica ai carbapenemici, gene blaIMP:
PrThr: Pt: Isolato: Ord: Sonda.amp.tar
- es-ESSpanish (SPAIN)
- gen bacteriano blaIMP resistente a carbapenem:
PrThr: Punto temporal: Aislado: Ord: Sonda con amplificación dirigida
LOINC FHIR® API Example - CodeSystem Request Get Info
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or email@example.com<mailto:firstname.lastname@example.org>. This may incur a fee in SNOMED International non-Member countries.
Copyright © 2019 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright